Полная версия:
Биохакинг
73
Lam, J. & Schneider, J. & Zhao, W. & Corley, D. (2013). Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. The Journal of The American Medical Association 310 (22): 2435–2342.
74
Theisen, J. et al. (2000). Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids. Journal of Gastrointestinal Surgery 4 (1): 50–54.
75
Helander, H. & Fändriks, L. (2014). Surface area of the digestive tract – revisited. Scandinavian Journal of Gastroenterology 49 (6): 681–689.
76
Irving, M. & Catchpole, B. (1992). ABC of colorectal diseases. Anatomy and physiology of the colon, rectum, and anus. British Medical Journal 304 (6834): 1106–1108. Review.
77
Miller, T. & Wolin, M. (1996). Pathways of acetate, propionate, and butyrate formation by the human fecal microbial flora. Applied and Environmental Microbiology 62 (5): 1589–1592.
78
А также ряд других биологически активных веществ, в том числе и мелатонин. – Прим. науч. ред.
79
Bollinger, R. et al. (2007). Biofilms in the large bowel suggest an apparent function of the human vermiform appendix. Journal of Theoretical Biology 249 (4): 826–831. Review.
80
Im, G. et al. (2011). The appendix may protect against Clostridium difficile recurrence. Clinical Gastroenterology and Hepatology 9 (12): 1072–1077.
81
Vons, C. et al. (2011). Amoxicillin plus clavulanic acid versus appendicectomy for treatment of acute uncomplicated appendicitis: an open-label, non-inferiority, randomised controlled trial. The Lancet 377 (9777): 1573–1579.
82
Jussila, A. et al. (2013). High and increasing prevalence of inflammatory bowel disease in Finland with a clear North-South difference. Journal of Crohns & Colitis 7 (7): e256-262.
83
Hou, J. & Abraham, B. & El-Serag, H. (2011). Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. The American Journal of Gastroenterology 106 (4): 563-573. Review.
84
Среди исследователей нет единого мнения о значимости кишечной проницаемости для развития различных заболеваний. В настоящее время значимость синдрома leaky gut («дырявого кишечника») считается преувеличенной. – Прим. науч. ред.
85
Fasano, A. (2011). Leaky gut and autoimmune diseases. Clinical Reviews in Allergy and Immunology 42 (1): 71–78.
86
Olendzki, B. et al. (2014). An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report. Nutrition Journal 13: 5.
87
Drago, S. et al. (2006). Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scandinavian Journal of Gastroenterology 41 (4): 408–419.
88
Festen, E. et al. (2011) A meta-analysis of genome-wide association scans identifies IL18RAP, PTPN2, TAGAP, and PUS10 as shared risk loci for Crohn’s disease and celiac disease. PLoS Genetics 7 (1): e1001283.
89
Herfarth, H. & Martin, C. & Sandler, R. & Kappelman, M. & Long M. D. (2014). Prevalence of a gluten-free diet and improvement of clinical symptoms in patients with inflammatory bowel diseases. Inflammatory Bowel Diseases 20 (7): 1194–1197.
90
Hall, J. (2010). Guyton and Hall Textbook of Medical Physiology. Philadelphia: Saunders.
91
European Association for the Study of Liver. (2012). EASL clinical practical guidelines: management of alcoholic liver disease. Journal of Hepatology 57(2): 399–420.
92
Chida, Y. & Sudo, N. & Kubo, C. (2006). Does stress exacerbate liver diseases? Journal of Gastroenterology and Hepatology 21 (1 Pt 2): 202–228. Review.
93
Milic, S. & Lulic, D. & Štimac, D. (2014). Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World Journal of Gastroenterology 20 (28): 9330–9337.
94
Pandit, A. & Sachdeva, T. & Bafna, P. (2012). Drug-Induced Hepatotoxicity: A Review. Journal of Applied Pharmaceutical Science 02 (05): 233–243.
95
Pak, E. & Esrason, K. & Wu, V. (2004). Hepatotoxicity of herbal remedies: an emerging dilemma. Progress in Transplantation 14 (2): 91–96. Review.
96
Stahre, M. & Roeber, J. & Kanny, D. & Brewer, R. & Zhang, X. (2014). Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States. Preventing Chronic Diseases 11: E109.
97
Michalopoulos, G. (2007). Liver regeneration. Journal of Cellular Physiology 213 (2): 286–300. Review.
98
Grant, D. (1991). Detoxification pathways in the liver. Journal of Inherited Metabolic Disease 14 (4): 421–430. Review.
99
Ellis, H. (2011). Anatomy of the gallbladder and bile ducts. Surgery (Orford) 29 (12): 593–596.
100
Schmidt, D. et al. (2010). Regulation of bile acid synthesis by fat-soluble vitamins A and D. The Journal of Biological Chemistry 285 (19): 14486–14494.
101
Houten, S. & Watanabe, M. & Auwerx, J. (2006). Endocrine functions of bile acids. The EMBO Journal 25 (7): 1419–1425. Review.
102
Ikemoto, S. et al. (1997). Cholate inhibits high-fat diet-induced hyperglycemia and obesity with acyl-CoA synthetase mRNA decrease. American Journal of Physiology 273 (1 Pt 1): E37–45.
103
Hofmann, A. (1999). The continuing importance of bile acids in liver and intestinal disease. Archives of Internal Medicine 159 (22): 2647–2658. Review.
104
Для профилактики камнеообразования в медицине используют препараты урсодезоксихолевой кислоты. – Прим. науч. ред.
105
Walcher, T. et al. (2009). Vitamin C supplement use may protect against gallstones: an observational study on a randomly selected population. BMC Gastroenterology 9: 74.
106
Koppisetti, S. et al. (2008). Reactive oxygen species and the hypomotility of the gall bladder as targets for the treatment of gallstones with melatonin: a review. Digestive Diseases and Sciences 53 (10): 2592–2603.
107
National Institutes of Health. (2012). Human Microbiome Project defines normal bacterial makeup of the body. Bethesda: National Human Genome Research Institute. [date of reference: 26.8.2014]
108
Ley, R. & Peterson, D. & Gordon, J. (2006). Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124 (4): 837–848. Review.
109
Guarner, F. & Malagelada, J. (2003). Gut flora in health and disease. The Lancet 361 (9356): 512–519. Review.
110
Sonomoto, K. & Yokota, A. (2011). Lactic Acid Bacteria and Bifidobacteria. Current Progress in Advanced Research. Norfolk: Caister Academic Press.
111
Wong, J. & de Souza, R. & Kendall, C. & Emam, A. & Jenkins, D. (2006). Colonic health: fermentation and short chain fatty acids. Journal of Clinical Gastroenterology 40 (3): 235–243. Review.
112
Guarner, F. & Malagelada, J. (2003). Gut flora in health and disease. The Lancet 361 (9356): 512–519. Review.
113
Jernberg, C. & Löfmark, S. & Edlund, C. & Jansson, J. (2010). Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 156 (Pt 11): 3216–3223.
114
Beaugerie, L. & Petit, J. (2004). Microbial-gut interactions in health and disease. Antibiotic-associated diarrhoea. Best Practice and Research Clinical Gastroenterology 18 (2): 337–352. Review.
115
Thomas, C. & Stevenson, M. & Williamson, D. & Riley, T. (2002). Clostridium difficile-associated diarrhea: epidemiological data from Western Australia associated with a modified antibiotic policy. Clinical Infectious Diseases 35 (12): 1457–1462.
116
Dethlefsen, L. & Huse, S. & Sogin, M. & Relman, D. (2008). The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biology 6 (11): e280.
117
World Health Organization. (2014). WHO’s first global report on antibiotic resistance reveals serious, worldwide threat to public health. Geneva: WHO. [date of reference: 26.8.2014]
118
Forsythe, P. & Kunze, W. (2013). Voices from within: gut microbes and the CNS. Cellular and Molecular Life Sciences 70 (1): 55–69. Review.
119
Cryan, J. & Dinan, T. (2012). Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature Reviews Neuroscience 13 (10): 701–712. Review.
120
Cryan, J & O’Mahony, S. (2011). The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterology and Motility 23 (3): 187–192.
121
Grenham, S. & Clarke, G. & Cryan, J. & Dinan, T. (2011). Brain-gut-microbe communication in health and disease. Frontiers in Physiology 2: 94.
122
Foster, J. & McVey Neufeld, K. (2013). Gut-brain axis: how the microbiome influences anxiety and depression. Trends in Neurosciences 36 (5): 305–312. Review.
123
Roberts, R. & Farmer, C. & Walker, C. (2018). The human brain microbiome; there are bacteria in our brains!. Program No. 594.08. Neuroscience Meeting Planner. San Diego, CA: Society for Neuroscience, 2018. Online.
124
Mayer, E. (2011). Gut feelings: the emerging biology of gut-brain communication. Nature Revies Neuroscience 12 (8): 453–466. Review.
125
Welgan, P. & Meshkinpour, H. & Beeler, M. (1988). Effect of anger on colon motor and myoelectric activity in irritable bowel syndrome. Gastroenterology 94 (5 Pt 1): 1150–1156.
126
Travagli, R. & Hermann, G. & Browning, K. & Rogers, R. (2006). Brainstem circuits regulating gastric function. Annual Review of Physiology 68: 279–305. Review.
127
Mayer, E. (2000). The neurobiology of stress and gastrointestinal disease. Gut 47: 861–869.
128
Hughes, D. & Sperandio, V. (2008). Inter-kingdom signalling: communication between bacteria and their hosts. Nature Reviews Microbiology 6: 111–120.
129
Fasano, A. (2012). Leaky gut and autoimmune diseases. Clinical Reviews in Allergy and Immunology 42 (1): 71–78.
130
Hollander, D. (1999). Intestinal permeability, leaky gut, and intestinal disorders. Current Gastroenterology Reports 1 (5): 410–416. Review.
131
Hietbrink, F. (2009). Systemic inflammation increases intestinal permeability during experimental human endotoxemia. Shock 32 (4): 374–378.
132
Frazier, T. & DiBaise, J. & McClain, C. (2011). Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. Journal of Parentereral and Enteral Nutrition 35 (5 Suppl): 14S–20S.
133
Neurath, M. (2014). Cytokines in inflammatory bowel disease. Nature Reviews Immunology 14: 329–342.
134
Aloisi, F. (2001) Immune function of microglia. Glia 36 (2): 165–179. Review.
135
Foster, J. & McVey Neufeld, K. (2013). Gut-brain axis: how the microbiome influences anxiety and depression. Trends in Neuroscience 36 (5): 305–312. Review.
136
Love, B. et al. (2013). Antibiotic exposure and risk of food allergy in children. 2013 Annual Meeting of the American Academy of Allergy, Asthma and Immunology. [date of reference: 20.9.2014]
137
Vadas, P. & Wai, Y. & Burks, W. & Perelman, B. (2001). Detection of peanut allergens in breast milk of lactating women. The Journal of the Ameican Medical Association 285 (13): 1746–1748.
138
Kosecka, U. & Berin, M. & Perdue, M. (1999). Pertussis adjuvant prolongs intestinal hypersensitivity. International Archives of Allergy and Immunology 119 (3): 205–211.
139
Nakayama, T. & Aizawa, C. & Kuno-Sakai, H. (1999). A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis accine combined with diphtheria and tetanus toxoids. The Journal of Allergy and Clinical Immunology 103 (2 Pt 1): 321–325.
140
O’Hagan, D. (2000). Vaccine Adjuvants. Preparation Methods and Research Protocols. Methods in Molecular Medicine. New York: Humana Press. [date of reference: 20.9.2014]
141
Jerschow, E. et al. (2012). Dichlorophenol-containing pesticides and allergies: results from the US National Health and Nutrition Examination Survey 2005–2006. Annals of Allergy Asthma and Immunology 109 (6): 420–425.
142
Ortolani, C. & Pastorello, E. (2006). Food allergies and food intolerances. Best Practice & Research. Clinical Gastroenterology 20 (3): 467–83. Review.
143
David, T. (2000). Adverse reactions and intolerance to foods. British Medical Bulletin 56 (1): 34–50.
144
Cardinale, F. et al. (2008). Intolerance to food additives: an update. Minerva Pediatrica 60 (6): 1401–1409. Review.
145
Weidenhiller, M. et al. (2012). Histamine intolerance syndrome (HIS): plethora of physiological, pathophysiological and toxic mechanisms and their differentiation. Zeitschrift für Gastroenterolie 50 (12): 1302–1309.
146
Maintz, L. & Novak, N. (2007). Histamine and histaminen intolerance. The American Journal of Clinical Nutrition 8 (5): 1185–1196.
147
David, T. (2000). Adverse reactions and intolerance to foods. British Medical Bulletin 56 (1): 34–50.
148
В США при синдроме непереносимости гистамина активно применяются пищевые добавки с диаминовой оксидазой. – Прим. науч. ред.
149
Hunt, P. & Susiarjo, M. & Rubio, C. & Hassold, T. (2009). The bisphenol A experience: a primer for the analysis of environmental effects on mammalian reproduction. Biology of Reproduction 81 (5): 807–813.
150
Singh, S. & Li, S. (2012). Epigenetic effects of environmental chemicals bisphenol a and phthalates. International Journal of Molecular Sciences 13 (8): 10143–10153.
151
Sathyanarayana, S. et al. (2013). Unexpected results in a randomized dietary trial to reduce phthalate and bisphenol A exposures. Journal of Exposure Science and Environmental Epidemiology 23 (4): 378–384.
152
Wagner, M. & Oehlmann, J. (2009). Endocrine disruptors in bottled mineral water: total estrogenic burden and migration from plastic bottles. Environmental Science and Pollution Research 16 (3): 278–286.
153
Ben-Jonathan, N. (1998). Xenoestrogens: prevalence, biologic effects, and mechanism of action. In: Puga, A. & Wallace, K. (eds.), Molecular Biology of the Toxic Response, 285–297. Boca Raton: CRC Press. [date of reference: 21.9.2014]
154
Peumans, W. & Van Damme, E. (1995). Lectins as plant defense proteins. Plant Physiology 109 (2): 347–352. Review.
155
Rüdiger, H. (1998). Plant lectins – more than just tools for glycoscientists: occurrence, structure, and possible functions of plant lectins. Acta Anatomica (Basel) 161 (1–4): 130–152. Review.
156
Pusztai, A. et al. (1993). Antinutritive effects of wheat-germ agglutinin and other N-acetylglucosamine-specific lectins. British Journal of Nutrition 70 (1): 313–321.
157
Dalla Pellegrina, C. et al. (2009). Effects of wheat germ agglutinin on human gastrointestinal epithelium: insights from an experimental model of immune/epithelial cell interaction. Toxicology and Applied Pharmacology 237 (2): 146–153.
158
Vasconcelos, I. & Oliveira J. (2004). Antinutritional properties of plant lectins. Toxicon 44 (4): 385–403. Review.
159
Freed, D. (1999). Do dietary lectins cause disease? British Medical Journal 318 (7190): 1023–1024.
160
Jönsson, T. & Olsson, S. & Ahrén, B. & Bøg-Hansen, T. & Dole, A. & Lindeberg, S. (2005). Agrarian diet and diseases of affluence – Do evolutionary novel dietary lectins cause leptin resistance? BMC Endocrine Disorders 5: 10.
161
Forbes, R &, Parker, H. & Erdman, J. Jr. (1984). Effects of dietary phytate, calcium and magnesium levels on zinc bioavailability to rats. The Journal of Nutrition 114 (8): 1421–1425.
162
Speijers, G. (1993). Cyanogenic glycosides. WHO Food Additives Series no. 30. www.inchem.org/documents/jecfa/jecmono/v30je18.htm [date of reference: 3.9.2015]
163
Coe, F. & Evan, A. & Worcester, E. (2005). Kidney stone disease. The Journal of Clinical Investigation 115 (10): 2598–2608. Review.
164
Holmes, R. & Kennedy, M. (2000). Estimation of the oxalate content of foods and daily oxalate intake. Kidney International 57 (4): 1662–1667.
165
Weiven, C. & Liebman, M. (2005). Oxalate content of legumes, nuts and grain-based flours. Journal of Food Composition and Analysis 18 (7): 723–729.
166
Francis, G. & Kerem, Z. & Makkar, H. & Becker, K. (2002). The biological action of saponins in animal systems: a review. British Journal of Nutrition 88 (6): 587–605. Review.
167
Shi, J. et al. (2004). Saponins from edible legumes: chemistry, processing, and health benefits. Journal of Medicinal Food 7 (1): 67–78. Review.
168
Johnson, I. & Gee, J. & Price, K. & Curl, C. & Fenwick, G. (1986). Influence of saponins on gut permeability and active nutrient transport in vitro. The Journal of Nutrition 116 (11): 2270–2277.
169
Keukens, E. et al. (1996). Glycoalkaloids selectively permeabilize cholesterol containing biomembranes. Biochimica et Biophysica Acta 1279 (2): 243–250.
170
Patel, B. et al. (2002). Potato glycoalkaloids adversely affect intestinal permeability and aggravate inflammatory bowel disease. Inflammatory Bowel Diseases 8 (5): 340–346.
171
Friedman, M. (2002). Tomato glycoalkaloids: role in the plant and in the diet. Journal of Agricultural and Food Chemistry 50 (21): 5751–5780. Review.
172
Fasano, A. (2011). Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiological Reviews 91 (1): 151–175.
173
Drago, S. et al. (2006). Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scandinavian Journal of Gastroenterology 41 (4): 408–419.
174
Doerge, D. & Sheehan, D. (2002). Goitrogenic and estrogenic activity of soy isoflavones. Environmental Health Perspectives 110 (Suppl 3): 349–353. Review.
175
Greer, M. (1957). Goitrogenic substances in food. The American Journal of Clinical Nutrition 5 (4): 440–444.
176
Sarne, D. (2010). Effects of the Environment, Chemicals and Drugs on Thyroid Function. Thyroid Disease Manager, 1–53. [date of reference: 15.7.2014]
177
Thompson, L. & Boucher, B. & Liu, Z. & Cotterchio, M. & Kreiger, N. (2006). Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutrition and Cancer 54 (2): 184–201.
178
Turner, J. & Agatonovic-Kustrin, S. & Glass, B. (2007). Molecular aspects of phytoestrogen selective binding at estrogen receptors. Journal of Pharmaceutical Sciences 96 (8): 1879–1885. Review.
179
Patisaul, H. & Jefferson, W. (2010). The pros and cons of phytoestrogens. Frontiers in Neuroendocrinology 31 (4): 400–419.
180
Hamilton-Reeves, J. et al. (2010). Clinical studies show no effects of soy protein or isoflavones on reproductive hormones in men: results of a meta-analysis. Fertility and Sterility 94 (3): 997–1007.
181
Tan-Wilson, A. et al. (1987). Soybean Bowman-Birk trypsin insoinhibitors: classification and report of a glycine-rich trypsin inhibitor class. Journal of Agricultural and Food Chemistry 35 (6): 974–981.
182
Preuss, H. (2009). Bean amylase inhibitor and other carbohydrate absorption blockers: effects on diabesity and general health. Journal of American College Nutrition 28 (3): 266–276.
183
Lalonde, M. (2011). An Organic Chemist’s Perspective on Paleo. Ancestral Health Symposium. http://www.slideshare.net/ancestralhealth/an-organicchemistss-perspective-on-paleo [date of reference: 15.7.2014]
184
Ibrahim, S. & Habiba, R. & Shatta, A. & Embaby, H. (2002). Effect of soaking, germination,cooking and fermentation on antinutritional factors in cowpeas. Die Nahrung 46 (2): 92–95.
185
Hotz, C. & Gibson, R. (2007). Traditional food-processing and preparation practices to enhance the bioavailability of micronutrients in plant-based diets. The Journal of Nutrition 37 (4): 1097–1100. Review.
186
Akande, E. & Fabiyi, E. (2010). Effect of processing methods on some antinutritional factors in legume seeds for poultry feeding. International Journal of Poultry Science 9 (10): 996–1001.
187
Hardy, H. & Harris, J. & Lyon, E. & Beal, J. & Foey, A. (2013). Probiotics, Prebiotics and Immunomodulation of Gut Mucosal Defences: Homeostasis and Immunopathology. Nutrients 5 (6):1869–1912.
188
Playford, R. et al. (1999). Bovine colostrum is a health food supplement which prevents NSAID induced gut damage. Gut 44 (5): 653–658.
189
Wang, B. et a. (2015). Glutamine and intestinal barrier function. Amino Acids 47 (10): 2143–2154.
190
Uehleke, B. & Ortiz, M. & Stange, R. (2012). Silicea gastrointestinal gel improves gastrointestinal disorders: a non-controlled, pilot clinical study. Gastroenterology Research and Practice 2012: 750750.
191
Wong, J. & de Souza, R. & Kendall, C. & Emam, A. & Jenkins, D. (2006). Colonic health: fermentation and short chain fatty acids. Journal of Clinical Gastroenterology 40 (3): 235–243. Review.
